| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/04/2007 | CN1942446A Pyrazoline derivatives useful for the treatment of cancer |
| 04/04/2007 | CN1942438A Proline derivatives used as pharmaceutical active ingredients for treating tumours |
| 04/04/2007 | CN1942195A Methods of treating hepatocellular carcinoma with DENSPM |
| 04/04/2007 | CN1942189A Use of 5,10-methylene tetrahydrofolate for the treatment of cancer |
| 04/04/2007 | CN1942184A Niosame having metal porphyrin complex embedded therein, process for it and drug with use thereof |
| 04/04/2007 | CN1940076A Conditionally replicating viral vectors and their use |
| 04/04/2007 | CN1940074A Construction, screen and use for stomach cancer target AFP gene siRNAs expression carrier |
| 04/04/2007 | CN1940069A Ig light chain variable region sequence and CDR3 sequence from human cancers and their use |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1940062A Liver-cancer stem cell, its separation and use |
| 04/04/2007 | CN1939910A Amino-metadiazine compound and its salt, its preparation and pharmaceutical use |
| 04/04/2007 | CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939530A Freeze-drying powder injection of Bozhi glycopeptide and its preparation |
| 04/04/2007 | CN1939396A Suberect spatholobus stem extract with antineoplastic function and its making method |
| 04/04/2007 | CN1939360A Java Brucea Fruit oil liquid capsules and preparation thereof |
| 04/04/2007 | CN1939358A Sarcandra glaber dispersant tablets |
| 04/04/2007 | CN1939346A Slug polysaccharide and its making method |
| 04/04/2007 | CN1939335A Cancer therapy using whole glucan particles and antibodies |
| 04/04/2007 | CN1939334A Freeze-drying powder for injecting lentinan and its content determination |
| 04/04/2007 | CN1939316A Microsphere containing adriamycin, its usage and preparation |
| 04/04/2007 | CN1939311A Ginseng sapogenin aglycone derivative biological preparation and its usage |
| 04/04/2007 | CN1939302A Siromosi medicinal composition and its making method |
| 04/04/2007 | CN1939299A Combinations comprising epothilone derivatives and alkylating agents |
| 04/04/2007 | CN1939296A Theapolyphenol composition and its preparation |
| 04/04/2007 | CN1308451C Tumor necrosis factor related ligand |
| 04/04/2007 | CN1308450C Methods and compositions for diagnosis and treatment of cancer |
| 04/04/2007 | CN1308447C Degraded agonist antibody |
| 04/04/2007 | CN1308431C Buck-wheat flavone vinega soft capsule and preparing method |
| 04/04/2007 | CN1308350C Process for preparing tuckahoe mycelium extracellular polysacchride with anti-tumor activity |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308327C Imidazopyridine derivatives |
| 04/04/2007 | CN1308321C Jujube kernel saponin derivative and its preparation method and use |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308302C Taxol enhancer compounds |
| 04/04/2007 | CN1308297C Phenyl sulfamate derivatives |
| 04/04/2007 | CN1308036C HPV polypeptide vaccine and its preparation method |
| 04/04/2007 | CN1308034C Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid |
| 04/04/2007 | CN1308029C Application of Chinese ginger extract in preparation of fatty acid synthetase inhibitor |
| 04/04/2007 | CN1308011C Method for extracting ganoderma lucidum spore fat soluble active substance |
| 04/04/2007 | CN1308010C Method for extracting active component of radix scutellariae |
| 04/04/2007 | CN1308000C Medicine containing pulsatilla root extract as active component for treating solid tumor |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/04/2007 | CN1307984C Drip pill for treating cervix cancer and its preparation method |
| 04/04/2007 | CA2570755A1 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 04/03/2007 | US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199238 Inhibitors of lysophosphatidic acid acyltransferase beta (LPAAT- beta ) activity; cancer screening and therapy |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199232 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/03/2007 | US7199229 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 04/03/2007 | US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents |
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199218 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/03/2007 | US7199161 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors |
| 04/03/2007 | US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient |
| 04/03/2007 | US7199151 DHA-pharmaceutical agent conjugates of taxanes |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy |
| 04/03/2007 | US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 04/03/2007 | US7199127 (2-chloropurin-9-yl)-tetrahydrothiophene-3,4-diols; anticarcinogenic agents selective to A3 adenosine receptors; breast cancer |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199122 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 04/03/2007 | US7199121 Protein tyrosine phosphatase inhibitor |
| 04/03/2007 | US7199113 Inhibiting tissue factor-dependent activation of blood-coagulation factors X or IX by contacting the tissue factor with a bisphosphonate blocking agent; anticoagulation |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198788 Administering pharmaceutical formulation comprising an anti-CD26 antibody, whereby the anti- CD26 antibody binds CD26 and arrests cell cycle for therapy of cancer |
| 04/03/2007 | US7198787 Preferentially kill mammary gland cancer cells; obtain cells, exposed to mixture of toxins, monitor cellular response to toxins |
| 04/03/2007 | US7198783 Sensitization of neoplastic cells to radiation therapy with reovirus |
| 04/03/2007 | US7198781 Chimeric interleukin-6 soluble receptor/ligand proteins |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 04/03/2007 | CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 04/03/2007 | CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/03/2007 | CA2288140C Farnesyltransferase inhibiting quinazolinones |
| 04/03/2007 | CA2205275C Vitamin d3 analogs |
| 04/03/2007 | CA2176510C Method for preparing concentrated biologically active silicon compounds |
| 04/03/2007 | CA2162397C Ligands for flt3 receptors |
| 04/03/2007 | CA2157530C Somatostatin analogs containing chelating groups and their radiolabeled compositions |
| 04/03/2007 | CA2107914C Method to profile and treat abnormal cells |
| 03/29/2007 | WO2007035841A1 Analogs of dehydrophenylahistins and their therapeutic use |
| 03/29/2007 | WO2007035489A2 Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents |
| 03/29/2007 | WO2007035428A1 Met kinase inhibitors |
| 03/29/2007 | WO2007035406A1 Antibodies to complementary peptides of thrombin or portions thereof |
| 03/29/2007 | WO2007035379A1 Polymorphs of tartrate salt of 2-[2-(3-(r)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6h-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
| 03/29/2007 | WO2007035309A1 Tyrosine kinase inhibitors |
| 03/29/2007 | WO2007034958A1 Anti-angiogenic composition comprising grain-derived component as active ingredient |
| 03/29/2007 | WO2007034917A1 Novel adenine compound |
| 03/29/2007 | WO2007034916A1 Novel adenine compound |
| 03/29/2007 | WO2007034882A1 Novel adenine compound |